Moderna Therapeutics Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 1,100
Employees
  • Stock Symbol
  • MRNA
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $127.03
  • (As of Friday Closing)

Moderna Therapeutics General Information

Description

Moderna Inc is engaged in creating transformative medicines based on messenger RNA, or mRNA. It transfers the information stored in the genes to the cellular machinery that makes all the proteins required for life. The firm is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases. Its clinical trials include mRNA-1647, mRNA-1893, mRNA-4157, and mRNA-2416 among others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 200 Technology Square
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000

Moderna Therapeutics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Moderna Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$127.03 $109.18 $17.68 - $130.06 $50.3B 396M 11.3M -$1.63

Moderna Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 25,367,779 5,493,633 3,977,726
Revenue 246,705 60,209 135,068 205,825
EBITDA (584,904) (515,613) (383,473) (250,562)
Net Income (597,869) (514,021) (384,734) (255,916)
Total Assets 4,650,873 1,589,422 1,962,149 1,084,489
Total Debt 212,294 132,364 33,489 15,687
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Moderna Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Moderna Therapeutics‘s full profile, request access.

Request a free trial

Moderna Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Moderna Therapeutics‘s full profile, request access.

Request a free trial

Moderna Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Moderna Inc is engaged in creating transformative medicines based on messenger RNA, or mRNA. It transfers the informatio
Drug Discovery
Cambridge, MA
1,100 As of 2020
00.00
00000000 00.00

00000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
0000000000000
Thousand Oaks, CA
00000 As of 0000
00.000
000000000000 00.000

0000000

uip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum d
0000 000000000
Tübingen, Germany
000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Moderna Therapeutics Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
0000000 Formerly VC-backed Tübingen, Germany 000 00.000 000000000 00.000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 000.00 000000000 000.00
00 000000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000&0 00000
00000 000000000000 Corporate Backed or Acquired Carlsbad, CA 000 0000 00000000000 0000
You’re viewing 5 of 32 competitors. Get the full list »

Moderna Therapeutics Executive Team (39)

Name Title Board Seat Contact Info
Stephane Bancel Chief Executive Officer & Board Member
Stephen Hoge MD President
David Meline Chief Financial Officer, Finance
Melanie Ivarsson Chief Development Officer
Melissa Moore Ph.D Chief Scientific Officer
You’re viewing 5 of 39 executive team members. Get the full list »

Moderna Therapeutics Board Members (17)

Name Representing Role Since
Elizabeth Tallett Self Board Member 000 0000
Israel Ruiz Self Board Member 000 0000
Noubar Afeyan Ph.D Self Chairman & Board Member 000 0000
Paul Sagan Self Board Member 000 0000
Robert Langer Ph.D Self Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Moderna Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Moderna Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Moderna Therapeutics‘s full profile, request access.

Request a free trial

Moderna Therapeutics Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 22-Oct-2015 000000000 0000 Therapeutic Devices
0000000000 01-Jan-2015 000000000 00000 Biotechnology
Onkaido 14-Jan-2014 Corporate 0000 Drug Discovery
To view Moderna Therapeutics’s complete investments history, request access »

Moderna Therapeutics Subsidiaries (2)

Company Name Industry Location Founded
Valera Therapeutic Devices Cambridge, MA 2015
0000000 Drug Discovery Cambridge, MA 0000
To view Moderna Therapeutics’s complete subsidiaries history, request access »

Moderna Therapeutics Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 22-Oct-2015 000000000 0000 Completed
  • 0000000 0000000000
Onkaido 14-Jan-2014 Corporate 0000 Completed
To view Moderna Therapeutics’s complete exits history, request access »